Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Importance of dose selection in novel oral anticoagulants for atrial fibrillation.

Grip LT, Giugliano RP.

Arch Cardiol Mex. 2012 Oct-Dec;82(4):308-11. doi: 10.1016/j.acmx.2012.10.001. Review.

PMID:
23168295
2.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
3.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
4.

Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.

Destephan C, Waller AH, Patel RJ, Dhruvakumar S, Mazza V, Gerula C, Maher J, Kaluski E.

Minerva Cardioangiol. 2012 Aug;60(4):425-31. Review.

PMID:
22858920
5.

Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation.

Lam YY, Ma TK, Yan BP.

Int J Cardiol. 2011 Jul 1;150(1):4-11. doi: 10.1016/j.ijcard.2010.10.017. Epub 2010 Nov 26. Review.

PMID:
21112648
6.

[New oral anticoagulants in atrial fibrillation].

Veltkamp R, Hacke W.

Nervenarzt. 2011 Feb;82(2):180, 182-4, 186-9. doi: 10.1007/s00115-010-3114-5. Review. German.

PMID:
21286676
7.

The need for new oral anticoagulants in clinical practice.

Hylek EM.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954. Review.

PMID:
19571764
8.

Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY.

Am J Med. 2010 Jul;123(7):638-645.e4. doi: 10.1016/j.amjmed.2009.11.025. Review.

PMID:
20609686
9.

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

Deedwania PC, Huang GW.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review.

PMID:
21740079
10.

Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation.

Baker WL, Phung OJ.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):711-9. Epub 2012 Aug 21. Review.

11.

New oral anticoagulants in atrial fibrillation.

Turpie AG.

Eur Heart J. 2008 Jan;29(2):155-65. Epub 2007 Dec 19. Review.

PMID:
18096568
12.

[New oral anticoagulants for the prevention of thromboembolism in atrial fibrillation: from clinical evidence to appropriate use].

Colonna P.

G Ital Cardiol (Rome). 2012 Nov;13(11 Suppl 1):3S-10S. doi: 10.1714/1179.13061. Review. Italian.

PMID:
23160014
13.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Selçuk H, Selçuk MT, Maden O.

Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8. Review. Turkish.

14.

Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents.

Ogawa S, Koretsune Y, Yasaka M, Aizawa Y, Atarashi H, Inoue H, Kamakura S, Kumagai K, Mitamura H, Okumura K, Sugi K, Yamashita T.

Circ J. 2011;75(7):1539-47. Epub 2011 Jun 9. Review.

15.

New anticoagulant treatments to protect against stroke in atrial fibrillation.

Potpara TS, Lip GY, Apostolakis S.

Heart. 2012 Sep;98(18):1341-7. doi: 10.1136/heartjnl-2012-301841. Epub 2012 Jun 22. Review.

PMID:
22730480
16.

Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).

Pengo V, Crippa L, Falanga A, Finazzi G, Marongiu F, Palareti G, Poli D, Testa S, Tiraferri E, Tosetto A, Tripodi A, Manotti C; Italian Federation of Thrombosis Centers.

Thromb Haemost. 2011 Nov;106(5):868-76. doi: 10.1160/TH11-05-0358. Epub 2011 Sep 22. Review.

PMID:
21946939
17.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
18.

New approaches to anticoagulation in atrial fibrillation.

Petersen P.

Curr Cardiol Rep. 2004 Sep;6(5):354-64. Review.

PMID:
15306092
19.

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Dentali F, Riva N, Crowther M, Turpie AG, Lip GY, Ageno W.

Circulation. 2012 Nov 13;126(20):2381-91. doi: 10.1161/CIRCULATIONAHA.112.115410. Epub 2012 Oct 15. Review.

20.

New anticoagulation drugs for atrial fibrillation.

Potpara TS, Lip GY.

Clin Pharmacol Ther. 2011 Oct;90(4):502-6. doi: 10.1038/clpt.2011.180. Epub 2011 Aug 10. Review.

PMID:
21934723

Supplemental Content

Support Center